Treatment of pulmonary thromboembolism using Arrow-Trerotola percutaneous thrombolytic device
¿µ³²ÀÇ´ëÇмúÁö 2014³â 31±Ç 1È£ p.28 ~ p.32
±èűÕ(Kim Tae-Kyun) - Eulji University Eulji General Hospital Department of Cardiology
¹ÚÁö¿µ(Park Ji-Young) - Eulji University Eulji General Hospital Department of Cardiology
¹èÁØÈ£(Bae Jun-Ho) - Eulji University Eulji General Hospital Department of Cardiology
ÃÖÀç¿õ(Choi Jae-Woong) - Eulji University Eulji General Hospital Department of Cardiology
À¯½Â±â(Ryu Sung-Kee) - Eulji University Eulji General Hospital Department of Cardiology
±è¹ÎÁ¤(Kim Min-Jung) - Eulji University Eulji General Hospital Department of Cardiology
±èÁغÀ(Kim Jun-Bong) - Eulji University Eulji General Hospital Department of Cardiology
¼ÕÀå¿ø(Sohn Jang-Won) - Yeungnam University College of Medicine Department of Internal Medicine
Abstract
Pulmonary thromboembolism (PTE) increases the pressure of the right ventricle and leads to symptoms and signs, such as dyspnea and hypoxia. If PTE causes hemodynamic instability, thrombolytic therapy should be considered. A mechanical thrombectomy is an alternative treatment to thrombolytic therapy and should be considered when thrombolytic therapy is contraindicated. Various devices are used in mechanical maceration and catheter-directed thrombolysis, but there is no standard mechanical device for PTE as yet. We report here on 2 clinical experiences of mechanical thrombectomy using the Arrow-Trerotola percutaneous thrombolytic device to remove residual clots after systemic thrombolysis in patients with massive PTE.
Å°¿öµå
Pulmonary embolism, Mechanical thrombectomy, Trerotola
KMID :
0370920140310010028
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)